Campaign Unavailable
We're sorry, this alert is no longer available. If you would like to learn more about ways you can take action, please visit ASH Grassroots Network.The short explanation of this alert was:
Help ASH reach out to the Senate to support stem cell research!
One year after the House of Representatives overwhelmingly passed the Stem Cell Research Enhancement Act (HR 810), the U.S. Senate still has been unsuccessful in moving forward with a vote on this legislation. Right now opponents of embryonic stem cell research are discussing introducing seven alternative stem cell bills that are intended to cloud the debate and obstruct support for HR 810.
HR 810 would expand the current federal policy on embryonic stem cell research by allowing federal funding on stem cell lines derived after August 9, 2001. This bill also establishes strict ethical guidelines for this field of research by requiring that federal funds not be used to derive stem cells or destroy embryos. ASH policy calls for support of federal funding of all avenues of stem cell research under National Institutes of Health federal research guidelines and with appropriate public oversight.
Now it is critical that embryonic stem cell research supporters send a clear and consistent message to the Senate—Approve HR 810 with no amendments and with no other measures that restrict any avenue of stem cell-related research.
To send a letter to your Senators, simply click the "Take Action" button below. ASH’s on-line advocacy system identifies your Senators for you and provides the message. We encourage you to customize the message to your Senators as much as possible, emphasizing (1) your positive feelings about embryonic stem cell research, and (2) how expanding this research beyond the number of currently approved lines will benefit patients.
If you have questions, or need more information, please contact ASH Government Affairs Manager Jeff Coughlin at jcoughlin@hematology.org or (202) 776-0544.
If you would like to view details on this alert, please visit here.
